RHAMM (CD168) Is Overexpressed at the Protein Level and May Constitute an Immunogenic Antigen in Advanced Prostate Cancer Disease

per Kilian M. Gust, Matthias D. Hofer, Sven R. Perner, Robert Kim, Arul M. Chinnaiyan, Sooryanarayana Varambally, Peter Moller, Ludwig Rinnab, Mark A. Rubin, Jochen Greiner, Michael Schmitt, Rainer Kuefer, Mark Ringhoffer
Publicat 2009-09-01